Sanara Medtech Stock Price Prediction
| SMTI Stock | USD 36.36 0.17 0.47% |
Oversold Vs Overbought
61
Oversold | Overbought |
EPS Estimate Next Quarter (0.70) | Wall Street Target Price 44 | EPS Estimate Current Quarter (0.62) | Quarterly Revenue Growth 0.352 |
Using Sanara Medtech hype-based prediction, you can estimate the value of Sanara Medtech from the perspective of Sanara Medtech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sanara Medtech to buy its stock at a price that has no basis in reality. In that case, they are not buying Sanara because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sanara Medtech after-hype prediction price | USD 36.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sanara |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sanara Medtech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sanara Medtech After-Hype Price Prediction Density Analysis
As far as predicting the price of Sanara Medtech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sanara Medtech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sanara Medtech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sanara Medtech Estimiated After-Hype Price Volatility
In the context of predicting Sanara Medtech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sanara Medtech's historical news coverage. Sanara Medtech's after-hype downside and upside margins for the prediction period are 33.47 and 39.73, respectively. We have considered Sanara Medtech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sanara Medtech is very steady at this time. Analysis and calculation of next after-hype price of Sanara Medtech is based on 3 months time horizon.
Sanara Medtech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sanara Medtech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sanara Medtech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sanara Medtech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 3.13 | 0.24 | 0.21 | 10 Events / Month | 4 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
36.36 | 36.60 | 0.66 |
|
Sanara Medtech Hype Timeline
Sanara Medtech is at this time traded for 36.36. The entity has historical hype elasticity of 0.24, and average elasticity to hype of competition of 0.21. Sanara is anticipated to increase in value after the next headline, with the price projected to jump to 36.6 or above. The average volatility of media hype impact on the company the price is about 146.26%. The price growth on the next news is projected to be 0.66%, whereas the daily expected return is at this time at 0.11%. The volatility of related hype on Sanara Medtech is about 166.31%, with the expected price after the next announcement by competition of 36.57. The company reported the previous year's revenue of 64.99 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 39.48 M. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Sanara Medtech Basic Forecasting Models to cross-verify your projections.Sanara Medtech Related Hype Analysis
Having access to credible news sources related to Sanara Medtech's direct competition is more important than ever and may enhance your ability to predict Sanara Medtech's future price movements. Getting to know how Sanara Medtech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sanara Medtech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BAX | Baxter International | 0.21 | 10 per month | 0.00 | (0.19) | 3.30 | (2.81) | 7.67 | |
| WST | West Pharmaceutical Services | 9.96 | 8 per month | 2.07 | (0.01) | 2.96 | (3.02) | 22.42 | |
| RMD | ResMed Inc | 1.08 | 9 per month | 1.67 | (0.05) | 2.08 | (2.59) | 11.88 | |
| ICUI | ICU Medical | (2.32) | 8 per month | 0.00 | (0.10) | 2.77 | (2.68) | 10.44 | |
| ATR | AptarGroup | 0.48 | 9 per month | 0.88 | 0.07 | 1.47 | (1.37) | 7.86 |
Sanara Medtech Additional Predictive Modules
Most predictive techniques to examine Sanara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sanara using various technical indicators. When you analyze Sanara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sanara Medtech Predictive Indicators
The successful prediction of Sanara Medtech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sanara Medtech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sanara Medtech based on analysis of Sanara Medtech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sanara Medtech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sanara Medtech's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0308 | 0.0324 | Price To Sales Ratio | 5.24 | 4.97 |
Story Coverage note for Sanara Medtech
The number of cover stories for Sanara Medtech depends on current market conditions and Sanara Medtech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sanara Medtech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sanara Medtech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sanara Medtech Short Properties
Sanara Medtech's future price predictability will typically decrease when Sanara Medtech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sanara Medtech often depends not only on the future outlook of the potential Sanara Medtech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sanara Medtech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.3 M | |
| Cash And Short Term Investments | 5.1 M |
Complementary Tools for Sanara Stock analysis
When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world |